INS and metabolic disease: It is important to mention that in the preclinical stages of metabolic disorders, the fasting serum parameters of lipids, glucose, and insulin may not present alterations, so it is necessary to evaluate other more predictive or sensitive tests to establish differences between individuals [18,32,33,34].